Thrombosis
News
SFDA approves product for hemophilia A
The Saudi Food & Drug Authority (SFDA) in the Kingdom of Saudi Arabia has approved efmoroctocog alfa (Elocta®), a recombinant human factor...
Conference Coverage
Consider switch to clopidogrel for DAPT early post ACS
PARIS – TOPIC trial provides new evidence-based DAPT strategy.
News
Bivalirudin not superior to heparin in real-world analysis
A new study suggests bivalirudin does not produce better outcomes than heparin in patients undergoing transradial primary percutaneous coronary...
News
Gene therapy granted fast track status for hemophilia A
The US Food and Drug Administration (FDA) has granted fast track designation to SB-525, a gene therapy intended for use in patients with...
News
Company stops developing hemophilia therapy
Dimension Therapeutics, Inc.
News
EMA recommends drug receive orphan designation for PNH
The European Medicines Agency (EMA) has recommended orphan drug designation for the complement C3 inhibitor APL-2 as a treatment for paroxysmal...
News
PRAC finds insufficient evidence of difference between FVIII products
There is no “clear and consistent evidence” that hemophilia A patients are more likely to develop inhibitors if they receive a recombinant factor...
News
Therapy receives orphan designation for hemophilia A
The US Food and Drug Administration (FDA) has granted orphan drug designation for SB-525 as a treatment for hemophilia A. SB-525 is a recombinant...
News
FDA grants therapy fast track status for hemophilia B
The US Food and Drug Administration (FDA) has granted fast track designation to SB-FIX for the treatment of hemophilia B. SB-FIX is a zinc finger...
Conference Coverage
Game over: VTE is a risk in obese, sedentary teens
MONTREAL – We all know about the risk of VTE on planes. What about that for obese children and adolescents?
News
Group publishes guidance for V/Q imaging in PE
A group of experts from various fields has published appropriate use criteria (AUC) for ventilation/perfusion (V/Q) imaging in patients with...